A Microchannel is an enclosed fluid pathway with cross-sectional dimensions typically between 1 and 1000 micrometers, fabricated into a chip or cartridge substrate to move, mix, separate, or react small volumes of liquid. In medical devices, microchannels form the fluidic backbone of lab-on-chip and point-of-care diagnostic systems.
What is a Microchannel?
A microchannel is a fabricated fluid pathway small enough that surface tension and viscous forces dominate over inertial ones, producing laminar flow instead of turbulent flow. Manufacturers mold, etch, or laser-cut microchannels into polymer, glass, or silicon substrates, then link them into networks that add mixers, valves, filters, and reaction chambers.
In medical devices, microchannels sit at the center of point-of-care diagnostic cartridges and lab-on-chip (LOC) platforms, along with some drug-delivery and organ-on-chip research tools. A microchannel network replaces a benchtop lab’s pipettes, centrifuges, and plate readers with a single disposable chip a clinician, or sometimes a patient, can use outside a central laboratory. That shift from lab to bedside is why microchannel technology has moved from academic research into commercial in vitro diagnostic (IVD) products over the past decade.
Why Microchannels Matter in Medical Device Development
Microchannel geometry controls whether a diagnostic assay works at all. A channel that is too wide loses the surface-to-volume ratio needed for fast mixing and heat transfer. One that is too narrow clogs with cells, clots, or particulates and produces a false negative. That is a patient safety issue: a missed or delayed diagnosis at the point of care can delay treatment for conditions such as sepsis or myocardial infarction.
Regulators treat microfluidic IVDs like any other diagnostic device. FDA reviews them under 21 CFR Parts 862, 864, or 866 depending on the analyte, and EU IVDR 2017/746 assigns a risk class from A to D on similar intended-use questions. A manufacturer who cannot show channel dimensions stay reproducible lot to lot will struggle to demonstrate analytical performance during a 510(k) or technical file review. Cost and time-to-market are also at stake: microchannel dimensions are usually locked into the injection-molding tool, so a design change found late can mean months of delay and a new tooling cycle.
How Microchannels Work
Most medical-grade microchannel networks share a small set of building blocks, even though the assay chemistry layered on top varies widely.
- Sample inlet and metering chamber: captures a fixed volume of blood, saliva, or another specimen.
- Transport channels: move fluid by capillary action, applied pressure, or centrifugal force, as in disc-based systems.
- Mixing and reaction zones: combine sample with reagents, often using herringbone grooves or serpentine paths to promote mixing without a rotor.
- Separation elements: filters or hydrodynamic structures that remove cells or debris before analysis, useful for plasma separation from whole blood.
- Detection zone: interfaces with an optical, electrochemical, or fluorescence sensor to produce a readable signal.
Material choice affects both function and regulatory pathway. Cyclic olefin copolymer (COC) and polymethyl methacrylate (PMMA) are common because they mold cleanly and have low autofluorescence, which matters for optical detection. Glass and silicon, more common in research-grade chips, offer tighter tolerances but cost more at volume. ISO 22916 gives interoperability requirements for microfluidic device dimensions, connections, and device classification, and ISO 10993 governs biocompatibility for any surface that contacts blood or another biological fluid. Devices with embedded software for pump control or result interpretation also fall under IEC 62304.
Common Challenges and Best Practices
Bubble formation is the most common failure mode in microchannel systems. A single trapped air pocket in a channel a few hundred micrometers wide can block flow or throw off an optical reading, so degassing and surface treatments that control wettability are standard countermeasures.
Scaling from a benchtop prototype to injection-molded production is another recurring problem. A channel cut by a laser in a lab prototype behaves differently once a molding tool reproduces it with draft angles and shrinkage. Teams that skip early design-for-manufacturing review often find their assay no longer performs the same way after transfer. Running design verification against the final molded geometry, not just the prototype, catches this before it reaches the clinic.
Reagent stability inside the channel is a third challenge. Dried reagents in a microchannel must survive shipping, temperature swings, and shelf-life testing without losing activity, so formulation and channel design need to be developed together, not in sequence. Teams that treat the chip and the chemistry as separate work streams tend to find integration problems late, when they are expensive to fix.
How SJML Helps with Microchannel Technology
SJML supports microchannel-based device programs across the full path from concept to production. Its design and engineering teams work on microfluidics and lab-on-chip platforms, covering mechanical and fluidic design, materials selection, and design verification and validation, with risk management under ISO 14971 and usability engineering under IEC 62366 built into the process. Manufacturing capabilities include cleanroom-controlled molding and assembly suited to disposable diagnostic cartridges, along with process validation and traceability. SJML’s QARA team supports regulatory strategy, classification, and technical documentation for microfluidic IVD submissions.
Talk to SJML’s engineering team →
Frequently asked questions
A microchannel is a single fluid pathway, while a microfluidic chip is the complete device containing a network of microchannels along with inlets, chambers, and sometimes sensors. A chip may contain many interconnected microchannels performing different functions, from sample metering to detection, whereas a microchannel by itself is just one segment of that larger network.
Cyclic olefin copolymer and polymethyl methacrylate are the most common substrates for commercial microfluidic cartridges because they mold well at volume and have low background fluorescence. Glass and silicon are used where tighter tolerances or chemical resistance matter more than production cost, typically in research-stage or specialized diagnostic devices.
Medical device microchannels typically range from about 1 to 1000 micrometers in cross-sectional dimension, roughly the width of a human hair down to a fraction of it. At this scale, fluid flow is laminar rather than turbulent, which makes mixing and separation predictable but also means channel geometry must be precise and reproducible.
Most microchannel-based diagnostic devices sold in the United States need FDA clearance or approval, typically through a 510(k) submission for moderate-risk in vitro diagnostics reviewed under 21 CFR Parts 862, 864, or 866, depending on the analyte. Higher-risk tests may require premarket approval, and manufacturers must also show consistent channel performance across production lots.
Yes. Cells, clots, or debris can block a microchannel, and trapped air bubbles are a common failure mode, especially in channels only a few hundred micrometers wide. Manufacturers address this through filter structures upstream of narrow channels, surface treatments that control wettability, and verification testing that challenges the device with real, not idealized, sample types.
Related terms
- Lab-on-Chip (LOC)
- Point-of-Care Diagnostics
- Design Verification
- ISO 14971 Risk Management
- In Vitro Diagnostic (IVD)
